IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

USPTO Grants Codexis Patent for Enzymes Used in Hepatitis-C Therapeutics

12:43 AM MDT | May 17, 2012 | Deepti Ramesh

Codexis (Redwood City, CA) says that the United States Patent and Trademark Office (USPTO; Alexandria, VA) has granted Codexis’ patent covering the biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of hepatitis-C therapeutics. The term of this patent does not expire until 2029. The patent is titled “Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds” and was issued as U.S. patent number 8,178,333. “This patent specifically...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa